Other languages genedrive plc

Equities

Delayed London S.E. Other stock markets 06:36:14 2024-04-26 am EDT			5-day change	1st Jan Change
5.392 ^GBX	-4.15%		-8.23%	-33.64%

Apr. 24	Genedrive enters clinical trial deal in US for MT-RNR1 US approval	AN
Apr. 03	FTSE 100 up thanks to US economic data	AN

Genedrive enters clinical trial deal in US for MT-RNR1 US approval	Apr. 24
FTSE 100 up thanks to US economic data	Apr. 03
Genedrive shares surge as UK's NICE backs test for ischaemic stroke	Apr. 03
AIM WINNERS & LOSERS: UK NICE backs Genedrive test; Corero renews deal	Apr. 03
Genedrive's Test Receives Draft Recommendation from UK's NICE	Apr. 03
EARNINGS AND TRADING: 888 advances US exit; Arrow ups reserve estimate	Mar. 28
Genedrive plc Reports Earnings Results for the Half Year Ended December 31, 2023	Mar. 28
Genedrive down as plans equity raise despite GBP800,000 tax credit	Mar. 15
Coro seals sale terms, Powerhouse makes good progress	Feb. 19
Genedrive Seeks Funding for Testing Kit Amid Funding Call Launch of UK-backed Program	Feb. 19
MoneySupermarket credits Insurance for growth in 2023	Feb. 19
Genedrive draws down GBP600,000 on prepayment facility	Jan. 02
Genedrive Secures Financing Under Equity Prepayment Facility	Jan. 02
AIM WINNERS & LOSERS: Genedrive shares jump on orders	Dec. 20
Genedrive shares surge as six countries receive first orders	Dec. 20
Genedrive Jumps on Receipt of Initial Orders for MT-RNR1 Products	Dec. 20
Genedrive plc Announces Initial Overseas Orders of Mt-RNR1 Id Kit	Dec. 20
600 Group disposal and funding talks continue	Dec. 04
Genedrive plc Announces the Genedrive MT-RNR1 Id Kit Is Now in Routine Use in the Trevor Mann Baby Unit	Dec. 04
Genedrive shares fall as annual loss widens but focused on investing	Nov. 30

No results for this search